Solid tumors, including gastrointestinal, lung, and skin cancers, are more commonly targeted by tumor-infiltrating lymphocyte (TIL) therapies and T-cell receptor (TCR) therapies rather than CAR T-cell therapies.

Authors

• Person: Not available Organization: The Cancer News
  Top Oncology Innovations That Shaped the First Half of 2025

Sources

• Top Oncology Innovations That Shaped the First Half of 2025 binaytara.org The Cancer News via serper

Referenced by nodes (2)

• CAR T-cell therapy concept
• solid tumors concept